NY-AQARA
17.5.2022 09:02:06 CEST | Business Wire | Press release
Aqara, a leading provider of smart home products, announced the debut of its brand stores on Amazon.it and Amazon.es . Since the launch of Aqara’s first European brand store on Amazon UK in July 2021, the smart home manufacturer has expanded its Amazon presence to France, Germany, Italy and Spain, making the comprehensive portfolio of Aqara products easily accessible for smart home users across Europe.
Aqara has been selling in Italy and Spain on the Apple Online Store and via local retailers, and the brand has become increasingly popular among the local users for the build quality, the accessible prices and the wide compatibility with major ecosystems including HomeKit, Alexa, and Google Home. The launch of its Amazon brand stores will bring more Aqara products to the local markets, ranging from smart home hubs, smart sensors, security cameras, wired and wireless switches, to smart shade controllers.
The product lineup of the Aqara brand stores on Amazon.it and Amazon.es include:
Camera Hub G3 - Aqara’s flagship pan-and-tilt home security camera with AI-enabled facial and gesture recognition, built-in Zigbee hub function, as well as wide third-party ecosystem support (HomeKit, Alexa, Google Home);
Camera Hub G2H Pro - An indoor HomeKit Secure Video camera for home security, with the Zigbee hub function to enhance home security and smart home automations;
Hub M2 - The versatile and future-proof smart home hub that connects all Aqara devices and allows seamless integration across Aqara sensors and home automation devices;
Hub M1S - The wireless control center of Aqara accessories enabling home automation, local alarm, and remote control of smart devices, while it can also be used as a night light, siren, or doorbell;
Hub E1 - Aqara’s smallest smart home hub with a UBS-A port and adjustable shaft, allowing it to be flexibly placed and charged by USB devices such as PCs, power strips and outlets;
Door & Window Sensor - It detects when a window or a door is open in real time, and enables push notifications or/and local siren when the door/window opens unexpectedly;
Temperature & Humidity Sensor - It monitors temperature, humidity and atmospheric pressure in real time, and can connect with other Aqara devices for home automations and scenes;
Motion Sensor - It detects human movements with passive infrared and can work with other Aqara products to set home automations and scenes;
Motion Sensor P1 - An enhanced version of the iconic Motion Sensor, with a prolonged battery life of up to 5 years, and the configurable detection timeout as well as sensitivity levels;
Water Leak Sensor - It detects flood, and enables push notifications or/and local alarm activation to protect the property;
Vibration Sensor - It detects vibration, tilt and drop, alerts users when unexpected movement is detected, and can be used for home automations and scenes;
TVOC Air Quality Monitor - It detects the level of total volatile organic compounds (TVOC) in the air, as well as temperature and humidity, and can be used to enable push notifications, local siren, and home automations;
Smart Wall Switch H1 EU * - Aqara’s first wall switch designed for Europe, supporting both round European wall boxes and 86 mm square wall boxes and available in both With Neutral and No Neutral versions;
Smart Plug EU - It automates ordinary home appliances, and enables the remote control and timer switch of lights, fans, and other appliances.
Roller Shade Driver E1 - A retrofit roller shade controller to automate regular beaded-cord roller blinds, allowing users to set the shades by mobile control, voice command, preset schedule or via home automations;
Wireless Switch H1 - A remote switch with 7 configurable actions to control smart home devices or home scenes;
Wireless Mini Switch - A versatile and compact switch with 3 configurable actions to control smart home devices or home scenes;
Cube - A versatile controlling cube that recognizes 6 gestures (push, shake, rotate, tap twice, flip 90°, and flip 180°) for smart home control.
To celebrate the launch, Aqara now offers a limited-time offer of 5% extra discount for purchases on its Amazon.it store and Amazon.es store with the promo code AMAZONITES** . The offering is valid through May 19, 2022.
* Smart Wall Switch H1 EU is not available on Amazon.it.
** Promo code can be combined with coupons. Offer excludes the Hub M1S, the Camera Hub G3 and the Door & Window Sensor on Amazon.it, and excludes the Camera Hub G3 on Amazon.es.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517005102/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom